Inhibiting histone deacetylase 2 (HDAC2) promotes functional recovery from stroke

Journal of the American Heart Association

Volumn 6, Issue 10, 2017, Pages

  Tang, Ying ^a,b   Lin, Yu Hui ^a,b   Ni, Huan Yu ^a,b   Dong, Jian ^a,b   Yuan, Hong Jin ^a,b   Zhang, Yu ^a,b   Liang, Hai Ying ^a,b   Yao, Meng Cheng ^a,b   Zhou, Qi Gang ^a,b   Wu, Hai Yin ^a,b   Chang, Lei ^a,b   Luo, Chun Xia ^a,b   Zhu, Dong Ya ^a,b,c  

^a Institution of Stem Cells and Neuroregeneration   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c The Key Laboratory of Precision Medicine of Cardiovascular Disease   (China)

Author keywords

Epigenetics; Functional recovery; Histone deacetylase 2; Histone deacetylase inhibitor; Stroke

Indexed keywords

GREEN FLUORESCENT PROTEIN; HISTONE DEACETYLASE 2; SHORT HAIRPIN RNA; TRICHOSTATIN A; VORINOSTAT; HDAC2 PROTEIN, MOUSE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROVASCULAR ACCIDENT; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CONVALESCENCE; CYLINDER TEST; DRUG MECHANISM; ELECTROPHYSIOLOGY; EPIGENETICS; FUNCTIONAL DISEASE; GENE EXPRESSION; GOLGI STAIN; GRID TEST; MALE; MICROINJECTION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PATHOPHYSIOLOGY; PHOTOTHROMBOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYNAPTIC TRANSMISSION; TASK PERFORMANCE; THROMBOSIS; UPREGULATION; YOUNG ADULT; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOTOR ACTIVITY; NERVE CELL; PATHOLOGY; TIME FACTOR;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; HYDROXAMIC ACIDS; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEURONAL PLASTICITY; NEURONS; RECOVERY OF FUNCTION; STROKE; TIME FACTORS;

EID: 85032174349     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.117.007236     Document Type: Article

References (33)

1. Mendis S, Davis S, Norrving B. Organizational update: the World Health Organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke. 2015;46:e121-e122.
2. Lang CE, Lohse KR, Birkenmeier RL. Dose and timing in neurorehabilitation: prescribing motor therapy after stroke. Curr Opin Neurol. 2015;28:549-555.
3. Carmichael ST. Themes and strategies for studying the biology of stroke recovery in the poststroke epoch. Stroke. 2008;39:1380-1388.
4. Ueno Y, Chopp M, Zhang L, Buller B, Liu Z, Lehman NL, Liu XS, Zhang Y, Roberts C, Zhang ZG. Axonal outgrowth and dendritic plasticity in the cortical peri-infarct area after experimental stroke. Stroke. 2012;43:2221-2228.
5. Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci. 2009;10:861-872.
6. Langley B, Brochier C, Rivieccio MA. Targeting histone deacetylases as a multifaceted approach to treat the diverse outcomes of stroke. Stroke. 2009;40:2899-2905.
7. Zhou L, Li F, Xu HB, Luo CX, Wu HY, Zhu MM, Lu W, Ji X, Zhou QG, Zhu DY. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat Med. 2010;16:1439-1443.
8. Sigler A, Mohajerani MH, Murphy TH. Imaging rapid redistribution of sensoryevoked depolarization through existing cortical pathways after targeted stroke in mice. Proc Natl Acad Sci USA. 2009;106:11759-11764.
9. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature. 2010;468:305-309.
10. Staley K. Stroke: recovery inhibitors under attack. Nature. 2010;468:176-177.
11. Robert T, Vanoli F, Chiolo I, Shubassi G, Bernstein KA, Rothstein R, Botrugno OA, Parazzoli D, Oldani A, Minucci S, Foiani M. HDACs link the DNA damage response, processing of double-strand breaks and autophagy. Nature. 2011;471:74-79.
12. Gräff J, Joseph NF, Horn ME, Samiei A, Meng J, Seo J, Rei D, Bero AW, Phan TX, Wagner F, Holson E, Xu J, Sun J, Neve RL, Mach RH, Haggarty SJ, Tsai LH. Epigenetic priming of memory updating during reconsolidation to attenuate remote fear memories. Cell. 2014;156:261-276.
13. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009;10:32-42.
14. Aune SE, Herr DJ, Kutz CJ, Menick DR. Histone deacetylases exert classspecific roles in conditioning the brain and heart against acute ischemic injury. Front Neurol. 2015;6:145.
15. Kassis H, Shehadah A, Li C, Zhang Y, Cui Y, Roberts C, Sadry N, Liu X, Chopp M, Zhang ZG. Class IIa histone deacetylases affect neuronal remodeling and functional outcome after stroke. Neurochem Int. 2016;96:24-31.
16. Jin H, Zhu S, Wei JW, Wang J, Liu M, Wu Y, Wong LK, Cheng Y, Xu E, Yang Q, Anderson CS, Huang Y; ChinaQUEST (Quality Evaluation of Stroke Care and Treatment) Investigators. Factors associated with prehospital delays in the presentation of acute stroke in urban China. Stroke. 2012;43:362-370.
17. Ding J, Zhao Z, Wang C, Wang CX, Li PC, Qian C, Teng GJ. Bioluminescence imaging of transplanted human endothelial colony-forming cells in an ischemic mouse model. Brain Res. 2016;1642:209-218.
18. Baskin YK, Dietrich WD, Green EJ. Two effective behavioral tasks for evaluating sensorimotor dysfunction following traumatic brain injury in mice. J Neurosci Methods. 2003;129:87-93.
19. Zhu LJ, Li TY, Luo CX, Jiang N, Chang L, Lin YH, Zhou HH, Chen C, Zhang Y, Lu W, Gao LY, Ma Y, Zhou QG, Hu Q, Hu XL, Zhang J, Wu HY, Zhu DY. CAPONnNOS coupling can serve as a target for developing new anxiolytics. Nat Med. 2014;20:1050-1054.
20. Luo CX, Lin YH, Qian XD, Tang Y, Zhou HH, Jin X, Ni HY, Zhang FY, Qin C, Li F, Zhang Y, Wu HY, Chang L, Zhu DY. Interaction of nNOS with PSD-95 negatively controls regenerative repair after stroke. J Neurosci. 2014;34:13535-13548.
21. Nott A, Watson PM, Robinson JD, Crepaldi L, Riccio A. S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature. 2008;455:411-415.
22. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schütz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet. 1999;23:99-103.
23. Peng S, Zhao S, Yan F, Cheng J, Huang L, Chen H, Liu Q, Ji X, Yuan Z. HDAC2 selectively regulates FOXO3a-mediated gene transcription during oxidative stress-induced neuronal cell death. J Neurosci. 2015;35:1250-1259.
24. Formisano L, Guida N, Valsecchi V, Cantile M, Cuomo O, Vinciguerra A, Laudati G, Pignataro G, Sirabella R, Di Renzo G, Annunziato L. Sp3/REST/HDAC1/ HDAC2 complex represses and Sp1/HIF-1/p300 complex activates ncx1 gene transcription, in brain ischemia and in ischemic brain preconditioning, by epigenetic mechanism. J Neurosci. 2015;35:7332-7348.
25. Yang X, Wu Q, Zhang L, Feng L. Inhibition of histone deacetylase 3 (HDAC3) mediates ischemic preconditioning and protects cortical neurons against ischemia in rats. Front Mol Neurosci. 2016;9:131.
26. Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature. 2009;459:55-60.
27. Krämer OH. HDAC2: a critical factor in health and disease. Trends Pharmacol Sci. 2009;30:647-655.
28. Tran TS, Rubio ME, Clem RL, Johnson D, Case L, Tessier-Lavigne M, Huganir RL, Ginty DD, Kolodkin AL. Secreted semaphorins control spine distribution and morphogenesis in the postnatal CNS. Nature. 2009;462:1065-1069.
29. Wahl AS, Omlor W, Rubio JC, Chen JL, Zheng H, Schröter A, Gullo M, Weinmann O, Kobayashi K, Helmchen F, Ommer B, Schwab ME. Asynchronous therapy restores motor control by rewiring of the rat corticospinal tract after stroke. Science. 2014;344:1250-1255.
30. Zhou HH, Tang Y, Zhang XY, Luo CX, Gao LY, Wu HY, Chang L, Zhu DY. Delayed administration of Tat-HA-NR2B9c promotes recovery after stroke in rats. Stroke. 2015;46:1352-1358.
31. Baltan S, Bachleda A, Morrison RS, Murphy SP. Expression of histone deacetylases in cellular compartments of the mouse brain and the effects of ischemia. Transl Stroke Res. 2011;2:411-423.
32. Montgomery RL, Hsieh J, Barbosa AC, Richardson JA, Olson EN. Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proc Natl Acad Sci USA. 2009;106:7876-7881.
33. Takase K, Oda S, Kuroda M, Funato H. Monoaminergic and neuropeptidergic neurons have distinct expression profiles of histone deacetylases. PLoS One. 2013;8:e58473.